Finally, treatment of vitamin D deficiency (with baseline 25-hydroxyvitamin D levels <25 nmol / L) has been demonstrated to protect against moderate or severe exacerbation in patients with COPD. 24 Common drug interactions in pulmocrinology have been summarised in Table-7.